Rhino Resource Partners LP, together with its subsidiaries, produces, processes, and sells various grades of steam and metallurgical coal from surface and underground mines in the United States. As of December 31, 2013, it operated eight mines, including four underground and four surface mines located in Kentucky, Ohio, West Virginia, and Utah; and one underground mine in West Virginia through a joint venture. The company markets its steam coal primarily to electric utility companies as fuel for their steam powered generators; and metallurgical coal to steel and coke producers. It also manages and leases coal properties; owns and leases oil and gas mineral rights in the Cana Woodford region of western Oklahoma and Utica Shale region of eastern Ohio; mines and sells limestone from reserves located at Sands Hill mining complex to construction companies and road builders; and provides drill pad construction services for drilling operators. The company controlled an estimated 457.7 million tons of proven and probable coal reserves consisting of an estimated 438.0 million tons of steam coal and an estimated 19.7 million tons of metallurgical coal, as well as 277.0 million tons of non-reserve coal deposits. It also controlled an estimated 43.9 million tons of proven and probable coal reserves at the Rhino Eastern mining complex located in Central Appalachia through a joint venture. Rhino GP LLC operates as a general partner of the company. The company was founded in 2003 and is based in Lexington, Kentucky.
Blue Earth, Inc., together with its subsidiaries, provides energy efficiency and alternative/renewable energy solutions for small and medium sized commercial and industrial facilities. It also owns, manages, and operates independent power generation systems; and engineers, develops, constructs, operates, and maintains small and medium scale alternative/renewable energy power plants, including solar photovoltaic, combined heat and power, or on-site cogeneration and fuel cells. In addition, the company manufactures, sells, and installs commercial refrigeration gaskets and strip curtains, as well as sells and installs other energy efficiency products, such as EC motors, LED lights, and various control technologies. Further, it offers a range of energy solutions comprising specialized mechanical engineering, design, construction, and implementation of energy savings projects; energy conservation; energy infrastructure outsourcing; power generation; and energy supply and risk management. Additionally, the company provides maintenance and service programs, including heating, ventilation and air-conditioning (HVAC); and mechanical systems for design-build to repair and retrofit services, as well as finances alternative and renewable energy projects through industry relationships. It has strategic relationship with Kenyon Energy. Blue Earth, Inc. was founded in 2007 and is headquartered in Henderson, Nevada.
iBio, Inc., a biotechnology company, focuses on the commercialization of its proprietary plant-based protein expression technologies in the United States and internationally. Its proprietary technologies include iBioLaunch, a transformative platform technology for the development and production of therapeutic proteins and vaccines; and iBioModulator, a technology platform that enhances the potency and duration of the effect of prophylactic and therapeutic vaccines. The company's product candidates comprise IBIO-CFB03, a product for treatment of idiopathic pulmonary fibrosis; C1 Esterase Inhibitor, a plasma-derived protein; Alpha-Galactosidase, an enzyme replacement protein; and Palivizumab, a monoclonal antibody for the therapeutic protein market. Its vaccine products include H1N1 Influenza and H5N1 Influenza products that have completed Phase I human clinical trials, as well as yellow fever vaccine; malaria and hookworm parasitic pathogen vaccines; and human papillomavirus therapeutic vaccine. The company's product candidates also comprise Anthrax/Plague bacterial disease vaccine; and Anthrax, a monoclonal antibody for the biodefense market. It has strategic alliances and collaborations with various companies, such as Fraunhofer Center for Molecular Biology, GE Healthcare, FioCruz, and Caliber Biotherapeutics LLC. The company is headquartered in Newark, Delaware.
MagneGas Corporation, an alternative energy company, hydrogen based alternative fuel through the gasification of carbon-rich liquids in the United States and internationally. The company produces and distributes gas bottled in cylinders to the metalworking market as an alternative to acetylene. It offers MagneGas, a fuel that primarily comprises hydrogen; and Plasma Arc Flow refineries that produce gas. The company also sells and licenses the plasma arc technology for the processing of liquid waste. The company was founded in 2007 and is headquartered in Tarpon Springs, Florida.
Ocwen Financial Corporation, through its subsidiaries, is engaged in the servicing and origination of mortgage loans in the United States and internationally. The company's Servicing segment provides residential and commercial mortgage loan servicing, special servicing, and asset management services to owners of mortgage loans and foreclosed real estate. This segments residential servicing portfolio includes conventional; government insured; and non-agency loans, such as subprime loans. Ocwen Financial Corporation's Lending segment is involved in originating and purchasing conventional and government insured residential forward, and reverse mortgage loans primarily through its correspondent lending arrangements, as well as offers direct lending services. The company was founded in 1988 and is headquartered in Atlanta, Georgia.
ITT Educational Services, Inc. provides postsecondary degree programs in the United States. It offers master, bachelor, and associate degree programs to approximately 57,000 students, as well as short-term information technology and business learning solutions for career advancers and other professionals. The company's information technology programs include communications, network administration, network technology, software development, systems technology, and technical support; and electronics technology programs comprise communications, computer technology, electronics product design and fabrication, industrial electronics, instrumentation, and telecommunications. Its drafting and design programs consist of architectural and construction drafting, civil drafting, computer aided drafting, electrical and electronics drafting, interior design, landscape architecture, mechanical drafting, and multimedia communications; business programs comprise accounting, business administration, financial services, manufacturing, marketing and advertising, and sales; and criminal justice programs include corrections, cyber security, investigations, and security and policing. The company's nursing and health sciences programs comprise health information technology, medical assisting and administration, and nursing. As of December 31, 2013, it had 149 college locations, including 147 campuses and 2 learning sites in 39 states, and 1 training facility, as well as online programs to students who are located in 50 states. The company was founded in 1946 and is headquartered in Carmel, Indiana.
SinoCoking Coal and Coke Chemical Industries, Inc. operates as a coal and coke producer in the People's Republic of China. Its products include raw coal, washed coal, medium or mid-coal, coal slurries, coke, coal tar, and crude benzol. The company also provides metallurgical coke for steel manufacturing. In addition, it engages in coal trading activities. The company was founded in 1996 and is based in Pingdingshan, the People's Republic of China.
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its clinical products include Omidria, which has completed two Phase III clinical trials for use during intraocular lens replacement, including cataract and other lens replacement surgery; OMS103 that is in Phase III clinical program for use during arthroscopic procedures, such as partial meniscectomy surgery; and OMS824, which is in Phase II clinical trial for the treatment of CNS disorders comprising schizophrenia and Huntington's disease. Its clinical programs also consist of OMS721 that is in Phase II clinical trial for the treatment of various complement-related diseases and disorders, including thrombotic microangiopathies; OMS405, which is in Phase II clinical trial for the treatment and prevention of addiction to substances of abuse; and OMS201 that has completed Phase 1/Phase 2 clinical trial for use during urological procedures, such as ureterscopy for removal of ureteral or renal stones. The company's preclinical products and development programs comprise OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; and OMS616 for the control of blood loss during surgery, or resulting from trauma or other hyperfibrinolytic conditions. Its preclinical products also include G protein-coupled receptors platform for multiple disorders across therapeutic area; GPR17 for demyelinating disorders; and antibody platform for the discovery of monoclonal antibodies. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.
Oragenics, Inc. focuses on the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits. It develops and markets probiotic products comprising ProBiora3, an oral care probiotics that promote oral health for humans and pets under the Evora and ProBiora brands in approximately 13 countries worldwide. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus and EvoraKids for daily use by adults and children; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a product for the dental office channel. Its product candidates consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
Altisource Portfolio Solutions S.A. operates as a marketplace and transaction solutions provider for the real estate, mortgage, and consumer debt industries in the United States. Its Mortgage Services segment offers services that span the mortgage and real estate lifecycle for loan servicers, originators, and investors in single family homes. This segment provides asset management services, which include property preservation, property inspection, real estate owned (REO) asset management, and REO brokerage; residential property valuation; title insurance services; origination management services; and default management services, such as non-legal processing and related services for the supervision of foreclosure, bankruptcy, and eviction attorneys. The company's Financial Services segment offers collection and customer relationship management services. This segment provides asset recovery management services, such as post-charge-off consumer debt collection; and customer care and early stage collections, insurance and claims processing, call center, and analytical support services. Its Technology Services segment offers REALSuite of software products consisting of REALServicing, an enterprise residential mortgage loan servicing product; REALTrans, an electronic business-to-business exchange that automates and simplifies the ordering, tracking, and fulfilling of mortgage services; REALRemit, an electronic invoicing and payment system; REALDoc, a management platform that extracts, stores, and generates correspondence; and Equator's Solutions platforms that are used a la carte or together as an end-to-end solution, as well as information technology infrastructure services. The company serves sub-prime servicers, utility companies, commercial banks, servicers, mortgage bankers, financial service companies, and hedge funds, as well as a government-sponsored enterprise. Altisource Portfolio Solutions S.A. was incorporated in 1999 and is headquartered in Luxembourg.